Intra-Cellular Therapies (ITCI) Files Mixed Shelf
Tweet
Share
E-mailGet Alerts ITCI Hot Sheet
Join SI Premium – FREE
Intra-Cellular Therapies (NASDAQ: ITCI) has filed mixed shelf of:
COMMON STOCK
PREFERRED STOCK
DEBT SECURITIES
WARRANTS
RIGHTS
UNITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Exclusive: National Vision’s CEO on why the market got post-Q1 selloff wrong
- AudioEye names Matthew Domeyer as CFO, effective July 20
- uniQure reports early data from AMT-260 epilepsy gene therapy trial
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
The Children's Investment Fund (TCI)Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
